- In March 2024, Becton, Dickinson and Company (BD) launched the AGILITY clinical study to evaluate the safety and effectiveness of its Vascular Covered Stent in treating PAD. The study is being conducted internationally across the U.S., Europe, Australia, and New Zealand, with the goal of expanding treatment options for PAD
- In May 2024, The American Heart Association (AHA) published updated guidelines that emphasize early diagnosis, structured exercise therapy, and coordinated multispecialty care to reduce the risk of amputations in PAD patients. These guidelines also highlight racial and ethnic disparities in PAD outcomes.
- In May 2024, The American Heart Association introduced a comprehensive roadmap that emphasizes early diagnosis, structured exercise, and coordinated care to mitigate the risk of amputations for PAD patients. This initiative focuses on reducing healthcare disparities and improving patient outcomes.
- In March 2024, BD announced the enrollment of the first patient in its AGILITY study, a global clinical trial assessing the safety and effectiveness of its Vascular Covered Stent for PAD treatment. The goal is to offer a new solution for interventional treatments of PAD
